Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase III Study of PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related Hepatocellular Carcinoma After Surgical Resection (PATRON)

This study has been terminated.
(Due to Interim Analysis and business concerns)
Information provided by (Responsible Party):
Medigen Biotechnology Corporation Identifier:
First received: July 25, 2011
Last updated: March 30, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2015
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):